The largest database of trusted experimental protocols

4 protocols using pc12 cells

1

Ginsenosides and Alzheimer's Disease Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
UPLC-grade acetonitrile was purchased from Merck (Darmstadt, Germany). Formic acid was purchased from Sigma-Aldrich (Mo, USA). Leucine enkephalin was obtained from Waters Corporation (Milford, MA, USA). Distilled water was obtained from Watson's Food & Beverage (Guangzhou, China).
The PC12 cells were purchased from Jiangsu KeyGEN BioTECH Corp., Ltd (Nanjing, China). Ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rb3, ginsenoside Rc, ginsenoside Rd, ginsenoside Re, ginsenoside Rf, ginsenoside Rg1, notoginsenoside R1, 20(S)-notoginsenoside R2, notoginsenoside Fa, gypenosides A, and gypenosides XLIX were purchased from Chengdu Must Bio-Technology Co., Ltd. (Chengdu, China). The 20(S)-ginsenoside Rb2, galantamine HBr, and berberine were purchased from the National Institutes for Food and Drug Control (Beijing, China). The structure of these compounds is shown in Figure 2. Dulbecco's modified Eagle medium (DMEM) and phosphate buffer saline (PBS) were purchased from Jiangsu KeyGEN BioTECH Corp., Ltd. (Nanjing, China). Fetal bovine serum (FBS), trypsin, and dimethyl sulfoxide (DMSO) were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Amyloid β-protein fragment 25–35 was purchased from Sigma-Aldrich (St. Louis, MO, USA). YZG was produced by Guangxi Wanshoutang Pharmaceutical Co., Ltd., and formulated by water into suspension.
+ Open protocol
+ Expand
2

Baicalein Cytotoxicity Evaluation in PC12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC12 cells were purchased from the NanJing KeyGen Biotech Co. Ltd. (Nanjing, China). These cells were cultivated in high-glucose DMEM supplemented with 10% FBS, 100 U/mL of penicillin and 100 µg/mL of streptomycin at 37 °C under a humidified 5% CO2 atmosphere. Baicalein was dissolved in DMSO to prepare a 5 mM stock solution and diluted with serum-free media before use. PC12 cells were seeded into a 96-well plate at the density of 2 × 10 4 cells/well (100 μL) and cultured for 24 h. Next, the medium was changed, and the cells were treated with baicalein at 0, 1, 10, 20, 40, and 80 µM. Each concentration had six replicate wells, and the culture was continued for 24 h. To determine the effect of baicalein on cell viability, 20 µL of MTT (5 mg/mL) was added to each well. After 4 h, the resulting formazan crystals were dissolved by adding 150 μL of DMSO for 10–15 min. The absorption (O.D.) of each hole at 570 nm wavelength was measured using an enzyme-labelled instrument (Varioskan LUX; Thermo Fisher Scientific, Waltham, MA, USA). Cell viability was expressed as the percentage of the control.
+ Open protocol
+ Expand
3

Neuroprotective Effects of Fucoidan on PC12 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PC12 cells were obtained from the KeyGEN Biotech Co., Ltd. (Nanjing, China). The cells were routinely maintained in medium containing 10% (v/v) heat-inactivated fetal bovine serum (FBS) and 5% horse serum, penicillin (100 U/mL), and streptomycin (100 mg/mL) at 37 °C in a humidified incubator containing 5% CO2. Culture medium was changed every other day. After 24 h, cells were pretreated in the absence or presence of fucoidan (100, 200, and 400 μg/mL) and cultured for 24 h, followed by incubating with Aβ25–35 (25 μM) + d-Gal (10 mM) for an additional 48 h.
+ Open protocol
+ Expand
4

Quercetin Neuroprotection against Amyloid-β Toxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
PC12 cells were procured from Nanjing KeyGen Biotech Co. Ltd. (Nanjing, China). The cells were maintained in high-glucose DMEM containing 10% fetal bovine serum (FBS) and 1% P-S and incubated under 5% CO2 and 37 °C. PC12 cells in the logarithmic phase were seeded in 96-well (approximately 2 × 104/well) or 24-well (approximately 1 × 105/well) culture plates, incubated for 24 h, followed by the replacement of the medium.
The cells were classified into six groups, namely, blank control (normal medium); Aβ25–35 model (20 µM Aβ25–35, serum-free DMEM medium, 24 h); and quercetin (pretreatment with 1, 10, 20, and 40 µM quercetin for 2 h, followed by another 24 h treatment using 20 µM Aβ25–35). Each group was provided with six duplicate wells based on different measurement indexes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!